WALKING A TIGHT ROPE: SEVERE NO-REFLOW PHENOMENON WITH ADENOSINE-INDUCED VENTRICULAR TACHYCARDIA
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)33422-7
Abstract: The acute finding of a no-reflow phenomenon during a primary Percutaneous Coronary Intervention (PCI) is an important predictor of post-PCI prognosis. Several meta-analyses have indicated that intra-coronary adenosine may be useful however the risks are… read more here.
Keywords: phenomenon; rope severe; tight rope; walking tight ... See more keywords
Frequency and predictors of no-reflow phenomenon in patients with COVID-19 presenting with ST-segment elevation myocardial infarction.
Sign Up to like & getrecommendations! Published in 2021 at "Acta cardiologica"
DOI: 10.1080/00015385.2021.1931638
Abstract: OBJECTIVES Thrombotic process is triggered in the course of Coronavirus disease-2019 (COVID-19), which is a global pandemic, and both arterial and venous systems are affected. ST-elevation myocardial infarction (STEMI) that may develop in these patients… read more here.
Keywords: elevation myocardial; covid; predictors reflow; patients covid ... See more keywords
Predictive value of N-terminal pro-B-type natriuretic peptide (NT-pro BNP) combined with D-dimer for no-reflow phenomenon in patients with acute coronary syndrome after emergency of percutaneous coronary intervention.
Sign Up to like & getrecommendations! Published in 2021 at "Bioengineered"
DOI: 10.1080/21655979.2021.1988361
Abstract: Acute coronary syndrome (ACS) is a critical illness in cardiovascular disease. The purpose of this study was to investigate the value of N-terminal pro-B-type natriuretic peptide (NT-pro BNP) and D-dimer in predicting the occurrence of… read more here.
Keywords: bnp combined; value; emergency; reflow phenomenon ... See more keywords
The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Interventional Cardiology"
DOI: 10.1155/2022/5815274
Abstract: Objective The objective of this study is to analyze the impact of declining kidney function on the occurrence of the slow-flow/no-reflow phenomenon in patients with ST-elevation myocardial infarction (STEMI) treated with primary PCI (pPCI), as… read more here.
Keywords: reflow phenomenon; flow reflow; slow flow;
Relationship Between Systemic Inflammation Index and No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction
Sign Up to like & getrecommendations! Published in 2022 at "Angiology"
DOI: 10.1177/00033197221115562
Abstract: This study aimed to evaluate the relationship between no-reflow phenomenon and systemic inflammation index (SII) and to compare the predictive capacity of SII together with the neutrophil–lymphocyte ratio (NLR), and the platelet–lymphocyte ratio (PLR) in… read more here.
Keywords: myocardial infarction; reflow phenomenon; phenomenon; sii ... See more keywords
Efficacy and safety of intracoronary epinephrine for the management of the no-reflow phenomenon following percutaneous coronary interventions: a systematic-review study
Sign Up to like & getrecommendations! Published in 2023 at "Therapeutic Advances in Cardiovascular Disease"
DOI: 10.1177/17539447231154654
Abstract: Background: Currently, no pharmacological or device-based intervention has been fully proven to reverse the no-reflow phenomenon. Objectives: To assess the efficacy and safety of intracoronary (IC) epinephrine in the management of no-reflow phenomenon following percutaneous… read more here.
Keywords: review; efficacy safety; reflow phenomenon; phenomenon ... See more keywords
MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Sign Up to like & getrecommendations! Published in 2022 at "BMC Cardiovascular Disorders"
DOI: 10.1186/s12872-022-02556-2
Abstract: Introduction No-reflow phenomenon (NRP) is one of the complications that mostly occur during percutaneous coronary intervention (PCI). In this study, we comprehensively examined the relationship between the model for end-stage liver disease-XI (MELD-XI) score and… read more here.
Keywords: percutaneous coronary; myocardial infarction; meld score; reflow phenomenon ... See more keywords
Coronary No-Reflow Phenomenon in Clinical Practice.
Sign Up to like & getrecommendations! Published in 2018 at "Current pharmaceutical design"
DOI: 10.2174/1381612824666180702112536
Abstract: Timely delivered coronary revascularization with no residual anatomical stenosis does not always lead to prompt restoration of anterograde coronary flow and complete myocardial reperfusion. This condition is known as coronary no-reflow and is associated with… read more here.
Keywords: clinical practice; phenomenon clinical; coronary reflow; reflow phenomenon ... See more keywords
A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12040932
Abstract: The incidence of the no-reflow (NR) phenomenon varies depending on the diagnostic criteria used. If just the angiographic criteria are considered (i.e., a degree of thrombolysis in myocardial infarction ≤2), it will be found that… read more here.
Keywords: narrative review; reflow phenomenon; review classical; classical modern ... See more keywords
Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach
Sign Up to like & getrecommendations! Published in 2023 at "Diagnostics"
DOI: 10.3390/diagnostics13040709
Abstract: Systemic immune-inflammation index (SII), which is a good predictive marker for coronary artery disease, can be calculated by using platelet, neutrophil, and lymphocyte counts. The no-reflow occurrence can also be predicted using the SII. The… read more here.
Keywords: systemic immune; reflow phenomenon; gray zone; zone ... See more keywords
Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Sign Up to like & getrecommendations! Published in 2022 at "Global Heart"
DOI: 10.5334/gh.1111
Abstract: Background: Stress hyperglycemia is a common finding during acute myocardial infarction and associated with poor prognosis. To reduce the occurrence of no-reflow, prognostic factors must be identified before primary percutaneous coronary intervention (PPCI). Our objective… read more here.
Keywords: stress hyperglycemia; stress; reflow phenomenon; myocardial infarction ... See more keywords